These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22177248)

  • 21. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
    Mounajjed T; Zhang L; Wu TT
    Hum Pathol; 2013 Apr; 44(4):542-50. PubMed ID: 23079207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
    Ibrahim TR; Abdel-Raouf SM
    Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours.
    Majeed S; Mushtaq S; Azam M; Akhtar N; Hussain M; Loya A
    J Pak Med Assoc; 2018 Jul; 68(7):1029-1031. PubMed ID: 30317296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma].
    Bian YZ; Yao DF; Zhang CG; Li SS; Wu W; Dong ZZ; Qiu LW; Yu DD
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):260-5. PubMed ID: 21586223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis.
    Sun B; Huang Z; Wang B; Yu Y; Lin S; Luo L; Wang Y; Huang Z
    Med Sci Monit; 2017 Feb; 23():850-855. PubMed ID: 28207681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
    Anatelli F; Chuang ST; Yang XJ; Wang HL
    Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
    Wang FH; Wen JM; Vong HT; Yip YC
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm.
    Wang F; Jing X; Wang T; Li G; Li T; Zhang Q; Huang Y; Li J; Wang Y; Gao Y; Han T; Du Z
    Am J Clin Pathol; 2012 Jun; 137(6):937-45. PubMed ID: 22586053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between glypican-3 and Notch1 expressions in hepatocellular carcinoma].
    Peng F; Wu Z; Li X
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):590-2, 597. PubMed ID: 23644127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
    Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
    Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.
    Jin GZ; Dong H; Yu WL; Li Y; Lu XY; Yu H; Xian ZH; Dong W; Liu YK; Cong WM; Wu MC
    BMC Cancer; 2013 Mar; 13():161. PubMed ID: 23537217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
    Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
    Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
    Zhou S; Parham DM; Yung E; Pattengale P; Wang L
    Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
    Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
    Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.
    Jeon Y; Kim H; Jang ES; Hong S; Kim JW; Yoon YS; Cho JY; Han HS; Jeong SH
    APMIS; 2016 Mar; 124(3):208-15. PubMed ID: 26764243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.